Latest
Fosamax
& Related Newswire
6/19/2006 5:07:00 AM | Fosamax risk weighed 
=(0) This article is about a Massachusetts woman's decision to stop taking Fosamax after being informed of the risk of osteonecrosis of the jaw by her dental surgeon. The woman's dental work was elective, and another way to accomplish it was found, but in many cases extractions or other oral surgery is necessary even for patients on osteoporosis me...
Read More
6/16/2006 1:13:00 AM | State court to handle roughly 60 Novartis suits =(0) More than 60 pending lawsuits against drugmaker Novartis have been moved to a US District Court in Tennessee. The suits claim that the drugs Aredia and Zometa, both made by Novartis, caused them to suffer "jaw death" or osteonecrosis of the jaw. The plaintiffs claim that Novartis did not sufficiently warn doctors about this possibility. The en...
Read More
6/13/2006 10:14:00 PM | Breast Cancer, Osteoporosis And Bone Cancer Treatment Drugs May ... =(0) Patients and doctors need to be aware of the risks of biphosphonate drugs such as Fosamax. These drugs are widely prescribed for osteoporosis and some cancers because they slow down the process of bone cell removal and allow bone cells to last longer. However when the patient undergoes some dental procedures such as tooth extractions or other ...
Read More
6/13/2006 9:29:00 AM | Pricey New Bone Drug Brings No Added Benefit =(0) A government-funded study indicates that a new osteoporosis medication, Teriparatide (Forteo) works no better than alendronate (Fosamax) but is eight times more expensive. There may be patients for whom the new drug is indicated, for example, those with severe disease or who do not respond to standard treatment, but for most, the benefit does ...
Read More
6/3/2006 6:17:00 AM | Bone Drug Goes to Court =(0) A lawsuit is under way in New York requesting that Hoffman-LaRoche alter some of its claims regarding its osteoporosis drug Boniva. Proctor & Gamble, maker of rival drug Actonel, says that Boniva only reduces risk of spinal fracture while its drug and Merck's Fosamax affect other common fracture sites. Hoffman-LaRoche insists its claims a...
Read More
4/19/2006 2:42:00 PM | Merck in court over osteoporosis drug =(0) The drug maker Merck has yet another lawsuit to contend with, this time over its osteoporosis medication Fosamax. A class of patients in Florida alleges that they developed osteonecrosis of the jaw, a rare but painful and debilitating condition, as a result of Fosamax treatment and that Merck was negligent in disclosing the risk. Merck cl...
Read More
4/13/2006 6:38:00 AM | Merck under fire again as US lawsuit targets Fosamax =(0) New concerns arise over the class of osteoporosis medication known as biphosphonates. Merck, the maker of one of these drugs, Fosamax, is being sued for negligence in the promotion of this drug by not disclosing an alleged side effect, osteonecrosis of the jaw. This is a rare but painful condition in which the jawbone disintegrates, requiring ...
Read More
3/17/2006 12:52:00 PM | New Study Shows Women With Osteoporosis Preferred Once-Monthly ... =(0) This article concerns a study comparing two postmenopausal-osteoporosis medications, Boniva and Fosamax. It showed that a larger percentage of women would tend to stay on treatment and thus retain some protection against bone fracture when taking only one pill a month (Boniva) than one pill a week (Fosamax). Boniva belongs to the class of drugs kn...
Read More